Tue, January 14, 2020
Mon, January 13, 2020
Fri, January 10, 2020
Thu, January 9, 2020
Wed, January 8, 2020
Tue, January 7, 2020
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $30 on, Jan 8th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-30-on-jan-8th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $25 to $30 on, Jan 8th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $24 on, Tuesday, November 12th, 2019